The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 23,691 | 1,566,895 | SH | SOLE | 1,566,895 | 0 | 0 | ||
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 616 | 149,400 | SH | SOLE | 149,400 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 118,898 | 2,340,059 | SH | SOLE | 2,340,059 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 78,584 | 2,489,974 | SH | SOLE | 2,489,974 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 12,013 | 178,500 | SH | SOLE | 178,500 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 5,941 | 321,641 | SH | SOLE | 321,641 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 23,015 | 2,267,486 | SH | SOLE | 2,267,486 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 25,933 | 761,398 | SH | SOLE | 761,398 | 0 | 0 | ||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 8,288 | 658,266 | SH | SOLE | 658,266 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 22,188 | 1,356,250 | SH | SOLE | 1,356,250 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 845 | 279,921 | SH | SOLE | 279,921 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 5,064 | 525,284 | SH | SOLE | 525,284 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 22,248 | 2,563,138 | SH | SOLE | 2,563,138 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 10,521 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| I MAB | SPONSORED ADS | 44975P103 | 17,047 | 1,049,691 | SH | SOLE | 1,049,691 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 8,127 | 1,475,000 | SH | SOLE | 1,475,000 | 0 | 0 | ||
| ITEOS THERAPEUTICS INC | COM | 46565G104 | 14,506 | 450,776 | SH | SOLE | 450,776 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 18,501 | 340,214 | SH | SOLE | 340,214 | 0 | 0 | ||
| OMEGA THERAPEUTICS INC | COMMON STOCK | 68217N105 | 1,101 | 176,470 | SH | SOLE | 176,470 | 0 | 0 | ||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 3,021 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 5,015 | 55,800 | SH | SOLE | 55,800 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 17,123 | 813,456 | SH | SOLE | 813,456 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 6,762 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 13,507 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||